46
Methods for impurity profiling of heroin and cocaine
Method D9:
Abundance of stable isotopes
15
N and
13
C by Isotope Ratio MS
(IRMS)
Sources: J. R. Ehleringer and others, “Tracing the geographical origin of cocaine”,
Nature, vol. 408, 2000, pp. 311-312; see also E. Ihle and H. L. Schmidt, “Multielement
isotope analysis on drugs of abuse: possibility for their origin assignment”, Isotopes
in Environmental and Health Studies, vol. 32, 1996, pp. 226-228.
Rationale for use: This IRMS method measures the relative abundance of the stable
isotopes
15
N and
13
C. The method is designed for unadulterated samples.
Outcome: Provides geo-specific information. Aids in the evaluation of samples for
case-to-case evidential purposes (linkage determinations [55]). Provides additional
information required to confirm links between samples, that is, the method should be
used in conjunction with a major component analysis.
IV.
DATA HANDLING, INTERPRETATION
OF RESULTS AND APPROACH TO SETTING
UP PROFILING DATA COLLECTIONS
A critical factor for successful drug characterization and impurity profiling pro-
grammes is the availability of sufficiently comprehensive data collections for com-
parative purposes, within and between laboratories. While such data collections
can only be built gradually, the process must be continuous and ongoing.
With regard to inter-laboratory comparison of data, the experience gained in
heroin analyses, both in the 1980s in the United States by DEA and, more recently,
by a group of European forensic laboratories in a harmonization study [48], has
shown that retrospective inter-laboratory database searches are not likely to be an
attainable goal in the immediate future. These experiences have shown that inter-
laboratory comparison of data generated using only major component analyses
can even be problematic.
The most significant issue is quantitative reproducibility (variance) for sec-
ondary targets (i.e. not heroin or cocaine but other secondary alkaloids and impu-
rities). While this problem does not constitute an evidentiary issue, the variance
in the data is too large to allow for successful inter-laboratory database searches,
in other words, the average difference between samples of dissimilar origin his-
tory become ever smaller with increasing database size, because more groups of
samples from different origins start to overlap. In principle the incorporation of
trace impurity analysis data into a database search algorithm should greatly
enhance sample-to-sample comparison. Unfortunately, trace component analyses
generally have many more target analytes and typically the coefficients of vari-
ance in trace analysis are significantly greater than for major component analy-
sis. Hence, it is expected that the inclusion of trace component analysis data into
inter-laboratory database searches will significantly increase the complexity of the
comparison parameters without a comparable increase in comparison specificity.
It is because of these issues that nearly all retrospective database searches are per-
formed as an intra-laboratory operation.
A.
Data handling
It is clear that the use of ratios of quantities, rather than absolute quantities, pro-
vides significantly better comparison data as this approach greatly reduces the
47
48
Methods for impurity profiling of heroin and cocaine
magnitude of the analytical variance, in particular for the less abundant sample
components. For heroin and cocaine, one laboratory* has successfully applied
ratios for all major and minor components by expressing the ratios in terms of
the appropriate major analyte, morphine base or cocaine base. It is thought that
there is a significant advantage gained in employing this normalization calcula-
tion, as it allows the ready assessment of sample hydrolysis and, in some instances,
the positive comparison of two samples that are identical except for the extent of
hydrolysis. For cocaine, this entails summing the sample quantities of ecgonine,
ecgonine methyl ester, benzoylecgonine and cocaine, while for morphine it is cal-
culated from the sum of morphine, O3MAM, O6MAM and heroin. These calcu-
lations can be performed in several different manners where the exact method
employed for this calculation is much less important than is consistency in the
application. One example of such a calculation for morphine from a heroin sam-
ple is as follows:
Heroin hydrochloride sample
Quantitation results:
Heroin hydrochloride•H2O
= Hhcl
O6MAM hydrochloride•2-H2O
= O6hcl
O3MAM hydrochloride•2-H2O
= O3hcl
Morphine hydrochloride•3-H2O
= Mhcl
(303.45/375.85 * Mhcl) + (303.45/399.87 * (O3hcl +O6hcl)) +
(303.45/423.89 * Hhcl) = total morphine base content expressed as the
monohydrate.
While this calculation would be a tedious operation if performed by hand, it is a
trivial calculation for the computer. Using the data derived from major compo-
nent analyses, some laboratories have used in-house database search and classifi-
cation algorithms, in some cases with commercial neural network programs. The
success of those heroin and cocaine algorithms in determining sample origin is
due largely to the fact that both algorithms rely on the normalization of all com-
ponent ratios to morphine or cocaine content, respectively.
There are several other data handling approaches in current use by various
laboratories that also rely on the use of ratios in order to normalize the data.
Typically the ratios for cis- and trans-cinnamoylcocaine to cocaine and O6MAM
and acetylcodeine to heroin are determined. Some will also include ratios for tropa-
cocaine and/or norcocaine to cocaine, and papaverine and noscapine to heroin.
Then when two samples are found with very similar ratios, they are considered
to be possible “matches” and are selected for additional comparative analyses,
usually for trace components.
The majority of those who perform these additional trace component analy-
ses for heroin use the procedure of Neumann and Gloger [56] or a modification
of that procedure. This procedure is a simple sulphuric acid extract whereby the
*Personal communication from Don Cooper, retired, Special Testing and Research Laboratory, Drug
Enforcement Administration, Dulles, Virginia, United States, 2005.